title: Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel.
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
authors.forename: C
authors.initials: C
authors.lastname: Hudis
authors.forename: L
authors.initials: L
authors.lastname: Riccio
authors.forename: A
authors.initials: A
authors.lastname: Seidman
authors.forename: J
authors.initials: J
authors.lastname: Baselga
authors.forename: V
authors.initials: V
authors.lastname: Currie
authors.forename: D
authors.initials: D
authors.lastname: Fennelly
authors.forename: T
authors.initials: T
authors.lastname: Gilewski
authors.forename: D
authors.initials: D
authors.lastname: Lebwohl
authors.forename: M
authors.initials: M
authors.lastname: Moynahan
authors.forename: G
authors.initials: G
authors.lastname: Raptis
authors.forename: A
authors.initials: A
authors.lastname: Surbone
authors.forename: N
authors.initials: N
authors.lastname: Sklarin
authors.forename: T J
authors.initials: TJ
authors.lastname: Yao
authors.forename: D
authors.initials: D
authors.lastname: Keefe
authors.forename: L
authors.initials: L
authors.lastname: Norton
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D006321:Heart / Q000187:drug effects*; D006333:Heart Failure / Q000139:chemically induced / Q000175:diagnosis; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013318:Stroke Volume
chemical_list: D004317:Doxorubicin; D017239:Paclitaxel